IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancerMasataka Amisaki, Vinod P. Balachandran, Rebecca Yu et al.|Nature|2025Cited by 83
Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinomaAkihiro Ohmoto, Shunji Takahashi|Modern Pathology|2021Cited by 40
Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemiaAkihiro Ohmoto, Hermann Einsele, Shigeo Fuji et al.|Bone Marrow Transplantation|2022Cited by 18